摘要
近年来,随着国际上对肺动脉高压诊断分类的更新和药物治疗肺动脉高压研究的进展,使得本领域的临床研究成为备受关注的热点,尤其在肺动脉高压药物治疗的观念上,已从最初的单纯降低肺动脉压力发展到根据发病机制中的重要靶点进行干预,如阻止血管内皮细胞无序增生和血管重构、诱导内皮细胞凋亡等治疗上,并在临床上取得了明显的疗效。应该说,药物治疗正在发挥越来越重要的作用。现将近年药物治疗肺动脉高压的新进展概述如下。
出处
《中华结核和呼吸杂志》
CAS
CSCD
北大核心
2007年第9期654-656,共3页
Chinese Journal of Tuberculosis and Respiratory Diseases
参考文献18
-
1Takaoka S, Faul JL, Doyle R. Current therapies for pulmonary arterial hypertension. Semin Cardiothorac Vasc Anesth, 2007, 11:137-148.
-
2Barst R J, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med, 1996, 334:296-302.
-
3Mclaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation, 2002, 106 : 1477-1482.
-
4Lammers AE, Hislop AA, Flynn Y, et al. Epoprostenol treatment in children with severe pulmonary hypertension. Heart, 2007, 93: 739-743.
-
5Rubenfire M, McLaughlin VV, Allen RP, et al. Transition from intravenous epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension: a controlled trial. Chest, In press 2007.
-
6Gomberg-Maitland M, Tapson VF, Benza RL, et al. Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension. Am J Respir Crit Care Med, 2005,172 : 1586-1589.
-
7Humbert M, Sanchez O, Fartoukh M, et al. Short-term and long- term epoprostenol ( prostacyclin ) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study. Eur Respir J, 1999,13:1351-1356.
-
8Barst R J, McGoon M, McLaughlin V, et al. Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol, 2003, 41: 2119-2125.
-
9Gessler T, Schmehl T, Hoeper MM, et al. Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension. Eur Respir J, 2001, 17: 14-19.
-
10Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med, 2002, 346: 896- 903.
二级参考文献23
-
1Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med, 2004, 351:1425-1436.
-
2Ten Dijke P, Goumans MJ, Itoh F, et al. Regulation of cell proliferation by Smad proteins. J Cell Physiol, 2002, 191: 1-16.
-
3McLaughlin VV, Presberg KW, Doyle RL, et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest, 2004, 126: 78S-92S.
-
4Behr J, Borst MM, Winkler J, et al. A role for combination therapy in pulmonary arterial hypertension. Pneumologie, 2005, 59 : 730-735.
-
5Hoeper MM, Faulenbach C, Golpon H, et al. Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension. Eur Respir J, 2004, 24 : 1007-1010.
-
6Hoeper MM, Markevych I, Spiekerkoetter E, et al. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J, 2005, 26 : 858-863.
-
7Leuchte HH, Holzapfel M, Baumgartner RA, et al. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. J Am Coll Cardiol, 2004, 43: 764-770.
-
8Petkov V, Ziesche R, Mosgoeller W, et al. Aerosolized iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment. Thorax, 2001,56: 734-736.
-
9Itoh T, Nagaya N, Fujii T, et al. A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats. Am J Respir Crit Care Med, 2004, 169: 34-38.
-
10Wilkens H, Guth A, Konig J, et al. Effect of inhaled iloprost plus oral sildenafll in patients with primary pulmonary hypertension. Circulation, 2001, 104: 1218-1222.
同被引文献49
-
1李敏然,陈顺存,马刚.钙通道阻滞剂及L-精氨酸对肺动脉高压的影响[J].中华结核和呼吸杂志,1994,17(6):372-374. 被引量:2
-
2Barst RJ,Langleben D,Badesch D,菅鑫妍.使用选择性内皮素A受体拮抗剂sitaxsentan治疗肺动脉高压[J].中国处方药,2006,5(8):29-29. 被引量:38
-
3许蜀闽,郑绿珍,刘福玉,陈莉,王培勇.L-精氨酸和牛磺酸联合抗缺氧损伤及防治缺氧性肺动脉高压的研究[J].局解手术学杂志,2006,15(4):217-219. 被引量:4
-
4邝土光,王军,翟振国,王辰.波生坦治疗肺动脉高压疗效与安全性评价的Meta分析[J].中国医师进修杂志(内科版),2006,29(12):17-20. 被引量:5
-
5徐作军.多发性肌炎/皮肌炎的肺损害[J].中华结核和呼吸杂志,2007,30(4):245-247. 被引量:9
-
6Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential diagnosis of pulmonary arterial hypertension. J Am Coll Cardiol ,2004,43 : 40S-47S.
-
7Galie N, Ghofrani HA, Torbicki A,et al. Sildenalll citrate therapy for pulmonary arterial hypertension. N Engl J Med, 2005,353: 2148-2157.
-
8Humbert M, Trembath RC. Genetics of pulmonary hypertension: from bench to bedside. Eur Respir J, 2002,20:741-749.
-
9Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med, 2004,351:1425-1436.
-
10Klepetko W, Mayer E, Sandoval J, et al. Interventional and Surgical modalifies of treatment for pulmonary arterial hypertension. J Am Coll Cardiol, 2004, 43 ( 12 Suppl 5 ) : 73S- 80S.
引证文献7
-
1孙桂才.结缔组织病肺损害诊治进展[J].中国厂矿医学,2009,22(1):88-90. 被引量:1
-
2罗慰慈.临床医师应提高对肺动脉高压的认识[J].临床肺科杂志,2008,13(5):535-536. 被引量:2
-
3Marc Humbert,申玉静(译),荆志成(译).肺动脉高压的诊断与治疗[J].中华结核和呼吸杂志,2008,31(5):325-329. 被引量:9
-
4吴飞华,金剑,肖忠革,金芝贵,诸慧.肺动脉高压的药物治疗及其进展[J].现代中西医结合杂志,2010,19(14):1815-1817. 被引量:6
-
5戚克岭.肺动脉高压的治疗进展[J].华北煤炭医学院学报,2011,13(6):770-772.
-
6滕莉,耿韫.雾化吸入硝酸甘油治疗先天性心脏病合并肺动脉高压的护理观察[J].护理实践与研究,2012,9(12):49-50. 被引量:2
-
7滕莉.硝酸甘油雾化吸入控制继发性肺动脉高压临床观察及护理[J].护士进修杂志,2012,27(18):1688-1690. 被引量:2
二级引证文献21
-
1白震宁.老年干燥综合征并发肺部混合性感染2例报告[J].实用老年医学,2013,27(7):615-616. 被引量:1
-
2夏书月,姜彦多,王实.肺动脉高压新的临床分类与组织病理学改变[J].国际呼吸杂志,2009,29(6):356-360. 被引量:2
-
3严晓娟,马可忠,刘娟,汤永谦,刘文卫.特发性肺动脉高压4例[J].临床肺科杂志,2011,16(2):319-320. 被引量:1
-
4许愿愿,光雪峰.一例肺动脉高压致晕厥临床分析[J].云南医药,2011,32(1):130-131.
-
5王云丹.1例先心并发重度肺动脉高压的围术期护理[J].按摩与康复医学,2011,2(21):140-140.
-
6陈图敏,仇烨.超声心动图评价先天性心脏病合并肺高压右心室功能新进展[J].中国实用儿科杂志,2011,26(8):634-636. 被引量:5
-
7万自芬,张程,马丽,李敏,林洁如.慢性阻塞性肺疾病急性加重期合并肺动脉高压100例临床分析[J].检验医学与临床,2012,9(6):697-698. 被引量:12
-
8易欣,黎明江.特发性肺动脉高压误诊二例报告并文献复习[J].临床误诊误治,2013,26(1):24-26. 被引量:2
-
9兰平起,黄慧俐,李莉,王琨,刘朝伟.慢性阻塞性肺疾病合并不成比例肺动脉高压临床特征及病因分析[J].中华保健医学杂志,2013,15(3):234-236. 被引量:3
-
10张海霞,马全萍.赖诺普利治疗慢性阻塞性肺疾病急性加重期肺动脉高压的疗效观察[J].中国实用乡村医生杂志,2013(19):42-43. 被引量:1
-
1何富强,唐智,吴宗照.前列腺素E_1治疗慢性肝炎和重型肝炎疗效探讨[J].华南国防医学杂志,1995,9(1):59-60. 被引量:1
-
2李巧章.急性冠状动脉综合征107例临床分析[J].岭南急诊医学杂志,2012,17(5):341-342.
-
3郭志刚,侯玉清,马立勤,屠燕.急性冠状动脉综合征非ST段抬高患者心血管危险因素及其影像学特征[J].中国临床康复,2005,9(35):76-78.
-
4王宝恩.慢性肝炎的诊断、分级与分期[J].中华内科杂志,1995,34(4):223-225. 被引量:8
-
5荆志成,徐希奇.攻克肺动脉高压的长征之路:虽艰难但前途光明[J].中华内科杂志,2013,52(8):628-630. 被引量:7
-
6赵科研,柳克祥,侯明晓.干细胞治疗肺动脉高压研究的进展[J].心血管康复医学杂志,2010,19(3):322-324. 被引量:2
-
7庄微,王静,刘挺松.J波综合征研究进展[J].心血管病学进展,2017,38(2):134-137. 被引量:8
-
8陈辉,刘琳.特发性间质性肺炎的病理诊断分类及诊治分析[J].医学临床研究,2009,26(1):81-84. 被引量:1
-
9吴东海.皮肌炎知识十二问(二)[J].中老年保健,2017,0(4):8-9.
-
10安晓香,杨祖福.无胸痛急性冠脉综合征32例临床分析[J].中国急救医学,2005,25(3):181-182. 被引量:2